Journal
The New England Journal of Medicine
Publication Date
2014
Volume
13
Issue
370
Inclusive Pages
1008-1018
Document Type
Open Access Publication
DOI
pdf/10.1056/NEJMoa1314583
Rights and Permissions
Gopal, A. K., Kahl, B. S., Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., . . . Salles, G. A. (2014). PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. New England Journal of Medicine, 370(11), 1008-1018. Copyright © 2014 Massachusetts Medical Society. DOI: 10.1056/NEJMoa1314583. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1314583.
Recommended Citation
Wagner-Johnston, Nina D. and et al, "PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma." The New England Journal of Medicine. 13, 370. 1008-1018. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/2608
